In 2008, Kemwell set up a new R&D facility in Bangalore in partnership with the world’s leading pharmaceutical company, GlaxoSmithKline (GSK). This R&D center has been set up to cater to GSK’s global oral healthcare development projects.

Kemwell has been selected by GSK as a preferred partner for the development of Oral Care Products. Kemwell achieved this privileged status through their senior management commitment to diversification / innovation, their ability to deliver a new GMP facility, skilled manpower and their commitment to planning, delivery and quality. GSK and Kemwell share a relationship that spans over 20 years and have collaborated on several pharmaceutical manufacturing projects in the past. This relationship has now been extended to meet the R&D demands of GSK.

The Oral Care Unit (OCU) at Kemwell is a state of the art GMP facility suitable for all requisite development activities prior to technical transfer of product for manufacture into a GSK facility.